Acoziborole
Star1
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Acoziborole
- DrugBank Accession Number
- DB13086
- Background
SCYX-7158 has been used in trials studying the treatment of Trypanosomiasis, Parasitic Diseases, Protozoan Infections, and Trypanosomiasis, African.
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 367.11
Monoisotopic: 367.100286 - Chemical Formula
- C17H14BF4NO3
- Synonyms
- Not Available
- External IDs
- SCYX-7158
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as trifluoromethylbenzenes. These are organofluorine compounds that contain a benzene ring substituted with one or more trifluoromethyl groups.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Trifluoromethylbenzenes
- Direct Parent
- Trifluoromethylbenzenes
- Alternative Parents
- 4-halobenzoic acids and derivatives / Benzamides / Benzoyl derivatives / Fluorobenzenes / Aryl fluorides / Oxaborole derivatives / Boronic acid esters / Secondary carboxylic acid amides / Oxacyclic compounds / Organic metalloid salts show 7 more
- Substituents
- 1,2-oxaborole derivative / 4-halobenzoic acid or derivatives / Alkyl fluoride / Alkyl halide / Aromatic heteropolycyclic compound / Aryl fluoride / Aryl halide / Benzamide / Benzoic acid or derivatives / Benzoyl show 21 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2IOR2OO3GW
- CAS number
- 1266084-51-8
- InChI Key
- PTYGDEXEGLDNAZ-UHFFFAOYSA-N
- InChI
- InChI=1S/C17H14BF4NO3/c1-16(2)12-6-4-10(8-14(12)18(25)26-16)23-15(24)11-5-3-9(19)7-13(11)17(20,21)22/h3-8,25H,1-2H3,(H,23,24)
- IUPAC Name
- 4-fluoro-N-(1-hydroxy-3,3-dimethyl-1,3-dihydro-2,1-benzoxaborol-6-yl)-2-(trifluoromethyl)benzamide
- SMILES
- CC1(C)OB(O)C2=CC(NC(=O)C3=CC=C(F)C=C3C(F)(F)F)=CC=C12
References
- General References
- Not Available
- External Links
- PubChem Compound
- 44178354
- PubChem Substance
- 347829210
- ChemSpider
- 29407646
- ChEBI
- 183111
- ChEMBL
- CHEMBL2347704
- ZINC
- ZINC000198072921
- Wikipedia
- Acoziborole
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Not Yet Recruiting Treatment Human African Trypanosomiasis (HAT) 1 2, 3 Completed Treatment Gambiense Trypanosomiasis / Trypanosoma Brucei Gambiense; Infection 1 2, 3 Completed Treatment Trypanosoma Brucei Gambiense; Infection 1 2, 3 Recruiting Treatment Trypanosoma Brucei Gambiense; Infection 1 1 Completed Other Trypanosoma Brucei Gambiense; Infection 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00372 mg/mL ALOGPS logP 4 ALOGPS logP 4.67 Chemaxon logS -5 ALOGPS pKa (Strongest Acidic) 8.78 Chemaxon pKa (Strongest Basic) -4.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 58.56 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 84.42 m3·mol-1 Chemaxon Polarizability 33.26 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at October 21, 2016 02:51 / Updated at December 01, 2022 23:18